Intellectual property

Netherlands: Covid-19: Emergency Act temporarily amends Dutch Patents Act

Isabel Rutten

In June 2020, the Dutch House of Representatives passed an Emergency Act to temporarily amend the Dutch Patent Act, allowing patent holders and applicants more time to secure and preserve their patents. Before the introduction of the Emergency Act, the Covid-19 pandemic may have affected companies that owned patents or were in the process of Read More

Mexichem UK Ltd v Honeywell International Inc [2020] EWCA Civ 473 – Will a broad Arrow declaration fly?

Rafi Allos

An Arrow declaration is a form of discretionary relief granted by UK courts declaring that a product or process would have lacked novelty, or been obvious, at a specific point in time.  In contrast to declarations of non-infringement, an Arrow declaration can, in certain circumstances, be sought to achieve commercial certainty in relation to a Read More

Podcast: How to protect IP as part of a digital transformation strategy

Nigel Parker

Digitalisation is transforming businesses at an ever-increasing rate.  No matter the sector, technologies like cloud computing, the Internet of Things, AI and Blockchain are enabling streamlining of operations, new distribution channels and better customer insights.  Digital transformation is also creating new strategic imperatives as “digital natives” take market share from traditional industries. Partners Mark Ridgway Read More

China’s life sciences industry remains opportune despite Covid-19 coronavirus

David Shen

  While the novel Covid-19 coronavirus is at the top of the agenda for businesses around the world, and for good reason, it is creating challenges for medical and healthcare systems and signalling fundamental change across the life sciences industry. Activity in China’s life sciences market remains high as one of the few sectors to Read More

Evalve v Edwards – Review of competing public interests in grant of final injunctions

Marjan Noor

The issue of whether public interest considerations can be relied upon against the grant of a final injunction, or for a carve out in the injunction, is a very live one in disputes in relation to innovative medical devices and pharmaceuticals. In this decision, Edwards argued that, although its PASCAL product used to treat mitral Read More